JP2022529052A5 - - Google Patents
Info
- Publication number
- JP2022529052A5 JP2022529052A5 JP2021561852A JP2021561852A JP2022529052A5 JP 2022529052 A5 JP2022529052 A5 JP 2022529052A5 JP 2021561852 A JP2021561852 A JP 2021561852A JP 2021561852 A JP2021561852 A JP 2021561852A JP 2022529052 A5 JP2022529052 A5 JP 2022529052A5
- Authority
- JP
- Japan
- Prior art keywords
- cyclopropyl
- difluorophenyl
- amine
- purine
- propylthio
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19170003 | 2019-04-18 | ||
| EP19170003.8 | 2019-04-18 | ||
| EP19188639.9 | 2019-07-26 | ||
| EP19188639 | 2019-07-26 | ||
| PCT/EP2020/060819 WO2020212553A1 (en) | 2019-04-18 | 2020-04-17 | New pyrimidine derivatives for prevention and treatment of gram-negative bacterial infection, contamination and fouling |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022529052A JP2022529052A (ja) | 2022-06-16 |
| JP2022529052A5 true JP2022529052A5 (cg-RX-API-DMAC7.html) | 2023-04-24 |
| JP7588859B2 JP7588859B2 (ja) | 2024-11-25 |
Family
ID=70480222
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021561852A Active JP7588859B2 (ja) | 2019-04-18 | 2020-04-17 | グラム陰性細菌の感染、汚染、及びファウリングを予防及び治療するための新規ピリミジン誘導体 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US12318388B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3955929B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7588859B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102857084B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN113329753B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020258017B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112021012834A2 (cg-RX-API-DMAC7.html) |
| DK (1) | DK3955929T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2981773T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020212553A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3527571A1 (en) * | 2018-02-14 | 2019-08-21 | Université de Liège | Pyrimidine derivatives for prevention and treatment of bacterial infection |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU4928399A (en) * | 1998-07-27 | 2000-02-21 | M & M Laboratory Co., Ltd. | Ion complex, coating material, and coating method |
| WO2004021979A2 (en) * | 2002-09-06 | 2004-03-18 | Smithkline Beecham Corporation | PYRROLO[2, 3-d]PYRIMIDINE-4-YL AND PURIN-6-YL UREA COMPOUNDS |
| DE102005060690B4 (de) * | 2005-12-15 | 2008-09-25 | Capsulution Nanoscience Ag | Salze von Clopidogrel mit Polyanionen und ihre Verwendung zur Herstellung pharmazeutischer Formulierungen |
| WO2009034386A1 (en) | 2007-09-13 | 2009-03-19 | Astrazeneca Ab | Derivatives of adenine and 8-aza-adenine and uses thereof-796 |
| EP2236158A1 (en) * | 2009-03-30 | 2010-10-06 | Pharnext | New therapeutic approaches for treating neuroinflammatory conditions |
| WO2010118367A2 (en) * | 2009-04-10 | 2010-10-14 | Progenics Pharmaceuticals, Inc. | Antiviral pyrimidines |
| ES2731658T3 (es) | 2016-09-09 | 2019-11-18 | Univ Liege | Derivados triazolo(4,5-d)pirimidina para uso en la prevención y tratamiento de infección bacteriana |
| EP3527571A1 (en) | 2018-02-14 | 2019-08-21 | Université de Liège | Pyrimidine derivatives for prevention and treatment of bacterial infection |
| GB201910656D0 (en) | 2019-07-25 | 2019-09-11 | Univ Liege | New use of triazolo(4,5-d)Pyrimidine deerivatives |
-
2020
- 2020-04-17 BR BR112021012834-4A patent/BR112021012834A2/pt unknown
- 2020-04-17 CN CN202080010314.3A patent/CN113329753B/zh active Active
- 2020-04-17 WO PCT/EP2020/060819 patent/WO2020212553A1/en not_active Ceased
- 2020-04-17 EP EP20717066.3A patent/EP3955929B1/en active Active
- 2020-04-17 DK DK20717066.3T patent/DK3955929T3/da active
- 2020-04-17 ES ES20717066T patent/ES2981773T3/es active Active
- 2020-04-17 KR KR1020217037606A patent/KR102857084B1/ko active Active
- 2020-04-17 AU AU2020258017A patent/AU2020258017B2/en active Active
- 2020-04-17 JP JP2021561852A patent/JP7588859B2/ja active Active
-
2021
- 2021-05-21 US US17/327,551 patent/US12318388B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2014120792A (ru) | Способ лечения стромальных опухолей желудочно-кишечного тракта | |
| PE20230161A1 (es) | Inhibidores de proteinas kras mutantes | |
| CY1113670T1 (el) | Φαρμακευτικη συνθεση για τη θεραπεια της υπερδραστηριας ουροδοχου κυστης | |
| JOP20220069A1 (ar) | عوامل محللة لـ brd9 ثنائية الوظيفة وطرق لاستخدامها | |
| JP2016527217A5 (cg-RX-API-DMAC7.html) | ||
| JP2009541223A5 (cg-RX-API-DMAC7.html) | ||
| JP2005536475A5 (cg-RX-API-DMAC7.html) | ||
| EA202090977A1 (ru) | Новая комбинация активных агентов для лечения прогрессирующих фиброзирующих интерстициальных заболеваний легких (pf-ild) | |
| RU2015148189A (ru) | ПРОИЗВОДНЫЕ 2-АМИДОПИРИДО[4, 3-d]ПИРИМИДИН-5-ОНА И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ИНГИБИТОРОВ WEE-1 | |
| JP2020507589A5 (cg-RX-API-DMAC7.html) | ||
| RU2019141734A (ru) | Терапевтические соединения и композиции и способы их применения | |
| CY1116628T1 (el) | Ενωσεις σπειρο-οξινδολιου και χρηση αυτων ως θεραπευτικοι παραγοντες | |
| JP2010533160A5 (cg-RX-API-DMAC7.html) | ||
| RU2013121788A (ru) | Ингибиторы репликации вич | |
| JP2017515844A5 (cg-RX-API-DMAC7.html) | ||
| DK1780197T3 (da) | 5-Substituerede 2-phenylamino-benzamider som MEK-inhibitorer | |
| AR038914A1 (es) | Indazoles substituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion para fabricar un medicamento | |
| EA202191903A1 (ru) | Антипролиферативные соединения и вторые активные агенты для комбинированного применения | |
| JP2018522861A5 (cg-RX-API-DMAC7.html) | ||
| JP2015502974A5 (cg-RX-API-DMAC7.html) | ||
| JP2015535247A5 (cg-RX-API-DMAC7.html) | ||
| BR112015030578A2 (pt) | combinações farmacêuticas | |
| JP2010527984A5 (cg-RX-API-DMAC7.html) | ||
| WO2014106800A8 (en) | Substituted 2-amino pyrimidine derivatives as kinase inhibitors | |
| JP2015521617A5 (cg-RX-API-DMAC7.html) |